Viscoelastic and aggregometric point‐of‐care testing in patients with septic shock – cross‐links between inflammation and haemostasis
- 17 August 2012
- journal article
- intensive care-and-physiology
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 56 (10), 1277-1290
- https://doi.org/10.1111/j.1399-6576.2012.02750.x
Abstract
Background In the pathogenesis of sepsis, inflammation‐induced changes in coagulation play a pivotal role. Methods In total, 90 patients (30 patients with septic shock, 30 surgical patients following major abdominal surgery and 30 healthy volunteers) were enrolled. Blood samples from patients with septic shock were collected at the time of sepsis diagnosis as well as 24 h, 4 days, 7 days, 14 days and 28 days later. Samples from surgical patients with a post‐surgical inflammatory response were collected three times (before surgery, immediately after surgery and 24 h after surgery) and once from healthy volunteers. Thromboelastometry (ROTEM ®), as well as whole blood impedance aggregometry (Multiplate®) were performed. Additionally, plasma concentrations of interleukin‐6 and tumour necrosis factor‐alpha were measured using enzyme‐linked immunosorbent assay kits. Results Thromboelastometry lysis index was shown to be a reliable biomarker for septic shock. Furthermore, in septic patients with overt disseminated intravascular coagulation, thromboelastometry revealed signs indicating a hypocoagulable status, whereas patients without overt disseminated intravascular coagulation were found to be hypercoagulable. Platelet aggregation capability, as assessed by whole blood impedance aggregometry, was significantly reduced in septic patients with overt disseminated intravascular coagulation, whereas it was comparable with healthy volunteers and in septic patients without overt disseminated intravascular coagulation. Conclusion Viscoelastic and aggregometric point‐of‐care testing was shown to be potentially useful for bedside diagnosis of sepsis. Moreover, viscoelastic and aggregometric point‐of‐care testing was able to determine the phase of septic coagulopathy (hypercoagulability vs. hypocoagulability) and therefore identified patients at high risk for overt disseminated intravascular coagulation.Keywords
This publication has 46 references indexed in Scilit:
- First-line Therapy with Coagulation Factor Concentrates Combined with Point-of-Care Coagulation Testing Is Associated with Decreased Allogeneic Blood Transfusion in Cardiovascular SurgeryAnesthesiology, 2011
- Epidemiology and pathophysiology of cancer-associated thrombosisBritish Journal of Cancer, 2010
- Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrateCritical Care, 2010
- Comparison of thrombelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critical ill adultsCritical Care, 2010
- The protein C pathway and pathologic processesJournal of Thrombosis and Haemostasis, 2009
- Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometryActa Anaesthesiologica Scandinavica, 2009
- Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort studyCritical Care, 2009
- Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombastheniaPlatelets, 2009
- The Effect of Dilution on Plasma Coagulation Kinetics Determined by Thrombelastography Is Dependent on Antithrombin Activity and Mode of ActivationAnesthesia & Analgesia, 2004
- Thromboelastography for Monitoring Prolonged Hypercoagulability After Major Abdominal SurgeryAnesthesia & Analgesia, 2001